[O19] Oral Session 19　TR・臨床薬理
【E】

[O19-4] Not listed

^○高橋 俊二¹, Mizuno Nobumasa², Hasegawa Kosei³, Matsumoto Koji⁴, Han Shirong⁵, Takatsuki Tsutomu⁶, Jin Fan⁷, Nakagawa Kazuhiko⁸ (1.がん研究会有明病院 総合腫瘍科, 2.Department of Gastroenterology, Aichi Cancer Center Hospital, Nagoya, Japan, 3.Department of Gynecologic Oncology, Saitama Medical University International Medical Center, Saitama, Japan, 4.Division of Medical Oncology, Hyogo Cancer Center, Hyogo, Japan, 5.Biostatistics and Research Decision Sciences, MSD K.K, Tokyo, Japan, 6.Clinical Development, MSD K.K, Tokyo, Japan, 7.Clinical Development, Merck & Co., Inc., Kenilworth, NJ, USA, 8.Department of Medical Oncology, Kindai University Hospital, Osaka, Japan)